Skip to content
BODYDATA
JPEN
Research
Study type: Randomized controlled trialConfidence: Low

Glutathione as an oral whitening agent: a randomized, double-blind, placebo-controlled study

Arjinpathana N, Asawanonda P

Year2012
Sample sizen=60
JournalJournal of Dermatological Treatment
AuthorsArjinpathana N, Asawanonda P

Evidence is still limited and needs further study

Summary

Summary

A double-blind, placebo-controlled trial in 60 healthy medical students taking 500 mg/day of oral glutathione (split dose) for four weeks. Reductions in melanin index were significantly greater than placebo at only two of six measured sites — the right cheek and the sun-exposed left forearm. The authors note that long-term safety has not been established.

Source (read the original)

View source

DOI: 10.3109/09546631003801619

Key Findings

Key findings

  • 1

    Melanin index fell significantly more than placebo at only two of six measured sites

  • 2

    The remaining four sites showed no significant difference

  • 3

    Four weeks of supplementation at 500 mg/day

  • 4

    Participants were healthy medical students — a narrow population

  • 5

    The authors state that long-term safety has not been established

Related supplements

PR
  • Glutathione

    Blood glutathione rose over six months of supplementation — 30–35% in erythrocytes, plasma and lymphocytes (Richie et al., 2015). A four-week trial at the same dose found no change (Allen & Bradley, 2011)

The links below include affiliate links (PR).

Last checked: